Background illustration for clinical trials search

Paid Clinical Trials St. Louis

Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

ColoCare Study - Colorectal Cancer Cohort

for
Colorectal Cancer
Location: St Louis MO, Knoxville TN, Tampa FL, Salt Lake City UT,
Sponsor: University of Utah

Sex: All

Age: 18 - 70+

Code: NCT02328677

Recruiting

Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study

for
Wolfram Syndrome, Diabetes Mellitus, Optic Nerve Atrophy,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 0+

Code: NCT02841553

Recruiting

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

for
Colorectal Polyp, Colorectal Neoplasms, Colorectal Adenoma,
Location: St Louis MO, Indianapolis IN, Chicago IL, Ann Arbor MI,
Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All

Age: 65 - 70+

Code: NCT05612347

Recruiting

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

for
Atrial Fibrillation
Location: St Louis MO, Iowa City IA, Indianapolis IN,
Sponsor: Johns Hopkins University

Sex: All

Age: 22 - 70+

Code: NCT05836987

Phase3, Recruiting

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for
Myelofibrosis
Location: St Louis MO, Nashville TN, Chicago IL, Columbus OH,
Sponsor: Sumitomo Pharma America, Inc.

Sex: All

Age: 18+

Code: NCT04176198

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

for
Primary Myelofibrosis,
Location: St Louis MO, Kansas City KS, Cincinnati OH, Columbus OH,
Sponsor: Ajax Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06343805

Phase1, Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: St Louis MO, Indianapolis IN, Kansas City MO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase2, Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: St Louis MO, Nashville TN, Madison WI, Saint Paul MN,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase1, Recruiting

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

for
Relapsed/Refractory Multiple Myeloma
Location: St Louis MO, Chicago IL, Madison WI, Milwaukee WI,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT04973605

Phase1, Phase2, Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

for
Cancer, Advanced Cancer, Locally Advanced Carcinoma,
Location: St Louis MO, Nashville TN, Houston TX, Fairfax VA,
Sponsor: Angiex, Inc.

Sex: All

Age: 18+

Code: NCT06440005

Phase1, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Saint Louis MO, Creve Coeur MO, Springfield MO,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

for
Carcinoma, Non-Small-Cell Lung
Location: St Louis MO, Milwaukee WI, Detroit MI, Canton OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06855771

Phase2, Recruiting

Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors

for
Pediatric Recurrent Central Nervous System Tumors
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 0 - 25

Code: NCT03988283

Phase1, Recruiting

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

for
Breast Neoplasms
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT00353483

Recruiting

Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)

for
Adenoid Cystic Carcinoma, Colorectal Cancer
Location: St Louis MO, Ann Arbor MI, Toronto, Houston TX,
Sponsor: Rgenta Therapeutics Inc

Sex: All

Age: 18+

Code: NCT06462183

Phase1, Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: St Louis MO, Denver CO, Nashville TN, Columbus OH,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06120283

Phase1, Recruiting

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

for
Germ Cell Tumor
Location: St Louis MO, Oak Lawn IL, Chicago IL, Park Ridge IL,
Sponsor: University of Sydney

Sex: All

Age: 11 - 50

Code: NCT02582697

Phase3, Recruiting

A Global Prospective Observational Registry of Patients With Pompe Disease

for
Pompe Disease
Location: St Louis MO, Indianapolis IN, Little Rock AR,
Sponsor: Amicus Therapeutics

Sex: All

Age: 0+

Code: NCT06121011

Recruiting

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: St Louis MO, Germantown TN, Oak Lawn IL, Nashville TN,
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

for
Focal Epilepsy
Location: St Louis MO, Nashville TN, Chicago IL, Little Rock AR,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06132893

Phase2, Phase3, Recruiting